Inventor · disambiguated record
Daniel Fred Ortwine
Also filed as: ORTWINE DANIEL F · ORTWINE DANIEL FRED · ORTWINE Daniel
43 granted patents·31 pending applications·478 citations·filing 1985–2025
98Inventor score
Files withGENENTECH INC43WARNER LAMBERT CO11GILEAD CONNECTICUT INC3NESTED THERAPEUTICS INC3BERGERON PHILIPPE2
Top patents by PatentIndex Score
74 records- 0197US9980947B2Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2015·Granted May 29, 2018·17 cites·87 claims
- 0297US8933236B2N-substituted benzamides and methods of use thereofGENENTECH INC·Filed 2013·Granted Jan 13, 2015·50 cites·32 claims
- 0397US8716274B2Heteroaryl pyridone and aza-pyridone compoundsGENENTECH INC·Filed 2012·Granted May 6, 2014·38 cites·21 claims
- 0495US10045983B2Heteroaryl pyridone and aza-pyrodine compoundsGENENTECH INC·Filed 2017·Granted Aug 14, 2018·11 cites·14 claims
- 0595US8952169B2N-substituted benzamides and methods of use thereofGENENTECH INC·Filed 2013·Granted Feb 10, 2015·25 cites·43 claims
- 0694USRE48239EHeteroaryl pyridone and aza-pyridone compoundsGENENTECH INC·Filed 2018·Granted Oct 6, 2020·3 cites·27 claims
- 0794US8921353B2Heteroaryl pyridone and aza-pyridone compoundsGENENTECH INC·Filed 2014·Granted Dec 30, 2014·16 cites·22 claims
- 0893US9782405B2Heteroaryl pyridone and aza-pyrodine compoundsGENENTECH INC·Filed 2015·Granted Oct 10, 2017·9 cites·14 claims
- 0993US9238655B2Heteroaryl pyridone and aza-pyridone compoundsGENENTECH INC·Filed 2014·Granted Jan 19, 2016·12 cites·8 claims
- 1092US10966963B2Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2018·Granted Apr 6, 2021·10 cites·32 claims
- 1192US9845291B2Estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2015·Granted Dec 19, 2017·15 cites·14 claims
- 1292US9694002B2Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2016·Granted Jul 4, 2017·11 cites·10 claims
- 1392US9546164B2Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2015·Granted Jan 17, 2017·13 cites·38 claims
- 1491US9771376B2N-substituted benzamides and methods of use thereofGENENTECH INC·Filed 2016·Granted Sep 26, 2017·7 cites·19 claims
- 1590US8618107B2Pyridone and aza-pyridone compounds and methods of useBARBOSA ANTONIO J M·Filed 2011·Granted Dec 31, 2013·24 cites·30 claims
- 1690US2024270747A1Heteroaryl pyridone and aza-pyridone compoundsGENENTECH INC·Filed 2023·Application pending·0 cites
- 1788US8669251B28-fluorophthalazin-1(2H)-one compoundsGENENTECH INC·Filed 2012·Granted Mar 11, 2014·10 cites·24 claims
- 1888US8163763B2Pyrimidine compounds, compositions and methods of useBERGERON PHILIPPE·Filed 2009·Granted Apr 24, 2012·28 cites·33 claims
- 1988US7273877B25-substituted-4-[(substituted phenyl) amino]-2-pyridone derivativesWARNER LAMBERT CO·Filed 2004·Granted Sep 25, 2007·29 cites·17 claims
- 2086US2025114338A1TETRAHYDRO-PYRIDO[3,4-b]INDOLE ESTROGEN RECEPTOR MODULATORS AND USES THEREOFGENENTECH INC·Filed 2024·Application pending·0 cites
- 2185US6908917B2Chromone derivatives as matrix metalloproteinase inhibitorsWARNER LAMBERT CO·Filed 2003·Granted Jun 21, 2005·24 cites·15 claims
- 2285US2023279012A1Heteroaryl pyridone and aza-pyridone compoundsGENENTECH INC·Filed 2022·Application pending·0 cites
- 2384US6677355B1Hydroxamic acid compounds useful as matrix metalloproteinase inhibitorsWARNER LAMBERT CO·Filed 2000·Granted Jan 13, 2004·25 cites·10 claims
- 2484US5808062APyrone derivatives as protease inhibitors and antiviral agentsWARNER LAMBERT CO·Filed 1994·Granted Sep 15, 1998·24 cites·30 claims
- 2583US10654867B2Heteroaryl estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2019·Granted May 19, 2020·1 cites·5 claims
- 2680US9505785B2Pyridone and aza-pyridone compounds and methods of useGILEAD CONNECTICUT INC·Filed 2013·Granted Nov 29, 2016·3 cites·37 claims
- 2777US10053451B2Heterocyclic estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2016·Granted Aug 21, 2018·2 cites·10 claims
- 2877US8722676B2Bicyclic piperazine compoundsGENENTECH INC·Filed 2012·Granted May 13, 2014·3 cites·18 claims
- 2976US8754077B28-fluorophthalazin-1(2H)-one compoundsGENENTECH INC·Filed 2014·Granted Jun 17, 2014·2 cites·21 claims
- 3076US2021079002A1Heteroaryl pyridone and aza-pyridone compoundsGENENTECH INC·Filed 2020·Application pending·0 cites
- 3175US8598174B2Pyridazinones, method of making, and method of use thereofBARBOSA JR ANTONIO J M·Filed 2009·Granted Dec 3, 2013·5 cites·13 claims
- 3275US6297247B1Sulfonamide inhibitors of matrix metalloproteinasesWARNER LAMBERT CO·Filed 2000·Granted Oct 2, 2001·6 cites·15 claims
- 3374US7015237B2Pyridine matrix metalloproteinase inhibitorsWARNER LAMBERT CO·Filed 2004·Granted Mar 21, 2006·6 cites·5 claims
- 3473US2020062769A1Heteroaryl pyridone and aza-pyridone compoundsGENENTECH INC·Filed 2019·Application pending·0 cites
- 3572US12233052B2Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2021·Granted Feb 25, 2025·0 cites·32 claims
- 3670US6153612ASulfonamide inhibitors of matrix metalloproteinasesWARNER LAMBERT CO·Filed 1999·Granted Nov 28, 2000·22 cites·10 claims
- 3770US2019194203A1Heteroaryl pyridone and aza-pyrodine compoundsGENENTECH INC·Filed 2018·Application pending·0 cites
- 3869US10399939B2Tetrahydronaphthalene estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2016·Granted Sep 3, 2019·1 cites·35 claims
- 3969US2021093618A1Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 4068US10035801B2Pyrazolo compounds and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2014·Granted Jul 31, 2018·1 cites·15 claims
- 4167US2020108054A1Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 4265US2024239766A13-amino piperidyl sodium channel inhibitorsGENENTECH INC·Filed 2024·Application pending·0 cites
- 4364US2015224071A1N-substituted benzamides and methods of use thereofGENENTECH INC·Filed 2014·Application pending·0 cites
- 4464US2025120961A1P53 modulatorsNESTED THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4563US10344040B2Pyridone and aza-pyridone compounds and methods of useGILEAD CONNECTICUT INC·Filed 2018·Granted Jul 9, 2019·0 cites·16 claims
- 4663US6881743B2Pyridine matrix metalloproteinase inhibitorsWARNER LAMBERT CO·Filed 2002·Granted Apr 19, 2005·1 cites·13 claims
- 4762US2024228463A1Sodium channel inhibitors and methods of designing sameGENENTECH INC·Filed 2024·Application pending·0 cites
- 4861US2025289811A1Heterocyclic derivatives as mitogen-activated protein kinase (mek) inhibitorsNESTED THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4958US4604390AAntibacterial benzo(chalcogeno)[4,3,2-cd]indazolesWARNER LAMBERT CO·Filed 1985·Granted Aug 5, 1986·6 cites·46 claims
- 5057US2005037476A1Modified Wee1, crystals of peptide: inhibitor complexes containing such modified Wee1, and methods of use thereofPFIZER·Filed 2004·Application pending·0 cites
Showing the top 50 of 74 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Daniel Fred Ortwine files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →